5-isopropylbenzene-1,3-diamine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-isopropylbenzene-1,3-diamine
• 英文别名: 5-isopropyl-1,3-phenylenediamine；5-(Propan-2-yl)benzene-1,3-diamine；5-propan-2-ylbenzene-1,3-diamine
• 化学式: C₉H₁₄N₂
• 分子量: 150.224
• InChiKey: CDNWVKNRGVXDRL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  52
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-isopropylbenzene-1,3-diamine 在 potassium carbonate 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 仲丁醇 为溶剂， 反应 85.5h， 生成
  参考文献：
  名称：

  A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFRL858R/T790M mutant with improved pharmacokinetic properties

  摘要：

  Structural optimization of pyrido[2,3-d]pyrimidin-7-ones was conducted to yield a series of new selective EGFR(T790M) inhibitors with improved pharmacokinetic properties. One of the most promising compound 9s potently suppressed EGFR(L858R/T790M) kinase and inhibited the proliferation of H1975 cells with IC50 values of 2.0 nM and 40 nM, respectively. The compound dose-dependently induced reduction of the phosphorylation of EGFR and downstream activation of ERIC in NCI-H1975 cells. It also exhibited moderate plasma exposure after oral administration and an oral bioavailability value of 16%. Compound 9s may serve as a promising lead compound for further drug discovery overcoming the acquired resistance of non-small cell lung cancer (NSCLC) patients. (C) 2016 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2016.12.006
• 作为产物：
  描述：

  1,3-二溴-5-异丙基苯 在 copper(I) oxide 、 sodium azide 、 二甲基亚砜 、 L-脯氨酸 作用下， 以59%的产率得到5-isopropylbenzene-1,3-diamine
  参考文献：
  名称：

  A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFRL858R/T790M mutant with improved pharmacokinetic properties

  摘要：

  Structural optimization of pyrido[2,3-d]pyrimidin-7-ones was conducted to yield a series of new selective EGFR(T790M) inhibitors with improved pharmacokinetic properties. One of the most promising compound 9s potently suppressed EGFR(L858R/T790M) kinase and inhibited the proliferation of H1975 cells with IC50 values of 2.0 nM and 40 nM, respectively. The compound dose-dependently induced reduction of the phosphorylation of EGFR and downstream activation of ERIC in NCI-H1975 cells. It also exhibited moderate plasma exposure after oral administration and an oral bioavailability value of 16%. Compound 9s may serve as a promising lead compound for further drug discovery overcoming the acquired resistance of non-small cell lung cancer (NSCLC) patients. (C) 2016 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2016.12.006

文献信息

• 作为氨基封端的酰亚胺单体、有机杂化膜及其制备方法
  申请人：云南大学

  公开号：CN111303004B

  公开（公告）日：2023-09-29

  一种作为氨基封端的酰亚胺单体及其制备方法，涉及材料化学领域，该酰亚胺单体由二酐单体和二胺单体缩合而成，具有较佳的刚性。其结构新颖，原料易得，制备简单，可以作为有机杂化树脂材料中的氨基封端，明显改善有机杂化树脂材料的力学性能。一种有机杂化膜及其制备方法，该有机杂化膜采用上述酰亚胺单体与胺源化合物、交联剂、二醛化合物混合后加工得到。其不仅制备简单，操作方便，且该有机杂化膜机械性能和热稳定性优异，具有较佳的可锻塑、可修复、可回收性能。
• Lincomycin Derivatives and Antimicrobial Agents Comprising the Same as Active Ingredient
  申请人：Umemura Eijirou

  公开号：US20090156512A1

  公开（公告）日：2009-06-18

  This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R 1 represents a halide, nitro, substituted C 1-6 alkyl, optionally substituted amino, C 1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R 2 represents a hydrogen atom or C 1-6 alkyl, R 3 represents C 1-6 alkyl, all of R 4 , R 5 , and R 6 represent a hydrogen atom, R 7 represents C 1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.

  本发明提供了式（I）的化合物或其药理学上可接受的盐或溶剂，其中A代表芳基或单环或双环杂环基，R1代表卤素、硝基、取代的C1-6烷基、可选取代的氨基、C1-6烷氧羰基、可选取代的芳基、杂环基或杂环羰基，R2代表氢原子或C1-6烷基，R3代表C1-6烷基，R4、R5和R6均代表氢原子，R7代表C1-6烷基，m为1或2，n为1。这些化合物是新型的林可霉素衍生物，对耐药性肺炎球菌具有强大的活性。这些化合物可以用作抗微生物剂，并且对于预防或治疗细菌感染性疾病是有用的。
• COMPOSITION AND MOLDED ARTICLE
  申请人：Akita University

  公开号：EP3904450A1

  公开（公告）日：2021-11-03

  Provided is a composition comprising a fluorine-containing polymer and a silicon-containing compound, wherein the phosphorus content in the composition is 20 ppm or less.

  本文提供了一种由含氟聚合物和含硅化合物组成的组合物，其中组合物中的磷含量为 20 ppm 或更少。
• US4628097A
  申请人：——

  公开号：US4628097A

  公开（公告）日：1986-12-09
• US7871982B2
  申请人：——

  公开号：US7871982B2

  公开（公告）日：2011-01-18